GlaxoSmithKline to produce Combivir in China
BY Advocate.com Editors
November 27 2002 1:00 AM ET
British pharmaceutical company GlaxoSmithKline on Sunday submitted an application to China's State Drug Administration to produce the combination anti-HIV pill Combivir locally in Tianjin, China. If approved, Glaxo will be the first international drugmaker to manufacture an anti-HIV drug in China. The Tianjin plant would be able to start producing Combivir by the end of 2004. The domestically produced medication would cost significantly less than imported versions of the two-drug combination pill, Glaxo officials said. Combivir contains the nucleoside reverse transcriptase inhibitors 3TC and AZT.
- Mormon Missionary Positions
- Jamie Foxx Called Out for Crossing Line on Bruce Jenner Jokes
- Is This Photo Proof Mike Pence Knew RFRA Discriminates Against LGBTs?
- Charles Barkley: Move Final Four Out of Indiana
- Op-ed: Angelina Jolie's Choice Bolsters the Trans Argument
- Tim Cook on Standing Up to Discrimination: 'It’s Time for All of Us'